Laporte, J P <br/><br/>
GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen.  [electronic resource] 

 -  Lancet (London, England)  Sep 1991 
 - 601-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/0140-6736(91)90609-s  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Carmustine--therapeutic use<br/>Cytarabine--therapeutic use<br/>Drug Evaluation<br/>Etoposide--therapeutic use<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use<br/>Hematopoiesis--drug effects<br/>Hematopoietic System--drug effects<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Transplantation, Autologous